OptiBiotix offers UK probiotic supplements
This article was originally published in OTC Bulletin & The Rose Sheet
UK-based probiotics manufacturer OptiBiotix Health is launching in the UK a new supplement based on its patented lactobacillus plantarum, LPLDL, probiotic strain, aimed at the management of cholesterol.
You may also be interested in...
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.